Member Info for moonparty

And anyway, what's the problem with some of the rise being about covidity?
You portray the success of this in a very negative way.
Covidity is a good thing for the company and therefore the price has risen accordingly. It is something to be positive about. We now have another technology and trial to add to shareholder value.
It has been indicated in the last presentation that the trial is starting in Q2, so further news is imminent - which, as you infer, will see the sp go higher.
The inference that Scancell is a one trick covid-pony is way off the mark in my opinion.

I agree some of the rise can be put down to covidity, but progress in ANY of the trials will be a boost to the sp.
Remember Redmile invested pre-covidity.

Thanks LL, presume you mean a d v f n, they seemed a lot more expensive - they offer more markets, but I'm only interested in UK at present. I'll have a proper look over the weekend.

Thanks C7, think I'll give LSE a go for a month and see if I like it.

As it's quiet today, hope you don't mind if I ask a question about level 2?
I'm considering getting a level 2 package - I know LSE do one, but does anyone have experience with other providers, and able to give positives / negatives of the provider.
LSE seems competitive at £21.99 a month compared to others. Though II also do a level 2 offering for £20 a month.
If anyone has any opinions on these 2 in particular, I would be grateful for any views.

"FBI: Female (immuno)Body Inspector"

"My girlfriend went to the Scancell AGM and all i got was this lousy T-shirt (and some biscuits)"

Not missing anything, there was never going to be a grant announcement today.
We're not going to get a phase 1/2 grant, as that's already in place.
But phase 3 / commercialisation / worldwide distribution? - will take a bit longer to arrange a grant for that.

It seems highly unlikely the CEPI launch event will announce funding for specific companies?
I live in hope though.

The clues in the name - it's an anagram :) :)

Couldn't have put it better chippy.
Some posters are honest and some less so. Luckily the dishonest ones are usually pretty obvious.

Genuine question hasiba:
When did you buy your "few millions shares". I only saw you declare sells, not the buys?

Thought you'd left?

"Change of strategy...." No, really ?
Bye, thanks for coming.

You can buy 150K and sell 200k on auto.

You've got to question the motives of someone who spends all day Sunday being passive-aggressively mildly negative about a share.

there is nothing to worry about - 3 trials starting this year, at least one within weeks, Avidimab progressing nicely, talking to big pharma.
So everything going to plan and timescales holding up well.
What's not to like? Don't really think there will be a fall in the sp, but I will be up early to hit the Buy button if there is!

from 23.5 / 24.5 to 24 / 25.50
+2.1%

Unexpected. Don't think there is much liquidity - possibly Vulpes not releasing any more shares?

Anyway, I'm holding tight with or without news. Been here too long to risk missing out on the 'substantial multiples' of the current share price.

IMO there has to be news leading up to this or what's the point. There's only just been one.